BioWorld

April 29, 2010

View Archived Issues

For Now, MS Twin Study Yields More Questions, Not Answers

Read More

Lycera's Progress Triggers $11M in Second Part of Series A Round

Read More

Other News To Note

Read More

Stock Movers

Read More

Clinic Roundup

Read More

Huntington's Drug Snagged on Statistics; Another Trial Needed?

Shares of NeuroSearch A/S sank 30 percent when it turned out the firm's positive Phase III Huntington's disease trial was not quite so positive after all. (BioWorld Today) Read More

More Bush-Era Stem Cell Lines OK'd by NIH for Federal Funds

Read More